Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Exagen Diagnostics Inc market cap is N/A.
What is the 52-week high for Exagen Diagnostics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Exagen Diagnostics Inc 52 week high is N/A as of October 10, 2025.
What is the 52-week low for Exagen Diagnostics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Exagen Diagnostics Inc 52 week low is N/A as of October 10, 2025.
What is the PE ratio of Exagen Diagnostics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Exagen Diagnostics Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Exagen Diagnostics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Exagen Diagnostics Inc P/B ratio is None.
What is Exagen Diagnostics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Exagen Diagnostics Inc's EBITDA is N/A.
What is the 50-day moving average of Exagen Diagnostics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Exagen Diagnostics Inc 50-day moving average is N/A.
How many employess does Exagen Diagnostics Inc has?
